Tag: HST

Pharma warns new NICE rules will delay access to meds

by Selina McKee | Apr 3, 2017 | News | 0

Pharma companies are warning that changes to the way the National Institute for Health & Care Excellence (NICE) and NHS England (NHSE) assess new medicines, which came into affect on April 1, will hinder patient access to the latest treatments.

Patients call for halt to NICE changes

by Selina McKee | Mar 28, 2017 | News | 0

A coalition of almost 200 patient groups representing families affected by rare and genetic conditions have called for a halt to planned changes in the way therapies are appraised for NHS use, as they “threaten patients’ ability to access treatment, and work against the government’s goal of accelerating access to innovative medicines”.